Clinical Trial Update: Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors [Phase 2]

View source ↗

Summary

Phase 2 study of lapatinib in children and adults with Neurofibromatosis Type 2 and NF2-related tumors has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type 2
• Vestibular Schwannoma

Drugs mentioned

• Tykerb (lapatinib)

Snippet

Sponsor: NYU Langone Health | Conditions: Neurofibromatosis 2, Vestibular Schwannoma | Phase 2 | Status: COMPLETED | Results posted: 2016-03-22